Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

ILC1-like cells may contribute to hair loss in alopecia areata.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Discoid Lupus Erythematosus causes scalp plaques that can lead to hair loss, and antimalarial drugs are effective treatments.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

Watching, not removing, skin growths with moderate atypia and positive edges is okay; patients may get melanoma elsewhere, especially if they've had it before.

Platelet Rich Plasma can potentially help in restoring hair loss, but more research with larger groups is needed to confirm its effectiveness and standardize its use.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Adding colchicine stopped the girl's recurring heart issues caused by lupus.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Pimecrolimus cream is not effective for treating alopecia areata.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

Apremilast shows promise for several skin conditions but needs more research.

Effective treatments for severe alopecia areata are still lacking.

The document suggests a rare skin condition might be caused by a genetic phenomenon.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Melatonin may help with nerve pain, a hepatitis C drug is effective but has side effects, a treatment for mouth sores works but can cause blood issues, ear reconstruction with an implant is safe, HIV transmission from mother to child in Taiwan is now 0% with treatment, certain blood problems are more common in people with a tongue condition, a gene and being overweight are linked to hair loss in some women, a new technique could reduce radiation for lung nodule patients, a hepatitis treatment may lower cancer recurrence after a procedure, and adding extra screening improves tuberculosis detection in patients with lung infections.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Platelet-rich plasma may help in skin and hair treatments, and with muscle and joint healing, but more research is needed to fully understand its benefits and limitations.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Hair follicles in people with alopecia have lower levels of a key blood vessel growth protein.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Low dose oral minoxidil helps regrow hair in permanent chemotherapy-induced alopecia.

Cell aging can be both good and bad for tissue repair.